Evidence map›Paper›PMID 26395457›Full record

ArticleHuman molecular genetics2015

Integrative pathway genomics of lung function and airflow obstruction.

Sina A Gharib, Daan W Loth, María Soler Artigas, Timothy P Birkland, Jemma B Wilk, Louise V Wain, Jennifer A Brody, Ma'en Obeidat, Dana B Hancock, Wenbo Tang and 41 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Matrix metalloproteinases in emphysema.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  14. Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Article
  15. Article
  16. Revue des maladies respiratoires actualites · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 20 institutions in 13 countries.

Sina A GharibComputational Medicine Core, Center for Lung Biology, Department of Medicine, sagharib@u.washington.edu.
Daan W LothDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
María Soler ArtigasGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK, National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
Timothy P BirklandComputational Medicine Core, Center for Lung Biology.
Jemma B WilkHuman Genetics and Computational Biomedicine, Pfizer Global Research and Development, Cambridge, MA, USA.
Louise V WainGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK, National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
Jennifer A BrodyCardiovascular Health Research Unit.
Ma'en ObeidatUniversity of British Columbia, Centre for Heart Lung Innovation, Vancouver, BC, Canada.
Dana B HancockBehavioral and Urban Health Program, Behavioral Health and Criminal Justice Division, Research Triangle Institute (RTI) International, Research Triangle Park, NC, USA.
Wenbo TangDivision of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
Rajesh RawalInstitute of Genetic Epidemiology.
H Marike BoezenDepartment of Epidemiology, GRIAC Research Institute, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Medea ImbodenSwiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland.
Jennifer E HuffmanMRC Human Genetics Unit, MRC IGMM.
Lies LahousseDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Alexessander C AlvesSchool of Public Health.
Ani ManichaikulCenter for Public Health Genomics, Division of Biostatistics and Epidemiology, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Jennie HuiPathWest Laboratory Medicine WA, Nedlands, Australia, School of Pathology and Laboratory Medicine, School of Population Health, The University of Western Australia, Nedlands, Australia.
Alanna C MorrisonHuman Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX, USA.
Adaikalavan RamasamyDepartment of Medical and Molecular Genetics.
Albert Vernon SmithIceland Heart Association, Kopavogur, Iceland, University of Iceland, Reykjavik, Iceland.
Vilmundur GudnasonIceland Heart Association, Kopavogur, Iceland, University of Iceland, Reykjavik, Iceland.
Ida SurakkaPublic Health Genomics Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare (THL), Helsinki, Finland.
Veronique VitartMRC Human Genetics Unit, MRC IGMM.
David M EvansUniversity of Queensland Diamantina Institute, Translational Research Institute, 37 Kent St Woolloongabba, QLD 4102, Australia, MRC Integrative Epidemiology Unit, Oakfield Road, Oakfield Grove BS82BN, Bristol, UK.
David P StrachanPopulation Health Research Institute, St George's, University of London, London, UK.
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology.
Albert HofmanDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands, Netherlands Genomics Initiative (NGI)-Sponsored Netherlands Consortium for Healthy Aging (NCHA), Rotterdam, The Netherlands.
Sven GläserDepartment of Internal Medicine B, Pneumology, Cardiology, Intensive Care and Infectious Diseases, University Hospital Greifswald, Greifswald, Germany.
James F WilsonUsher Institute of Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, Scotland, UK.
Kari E NorthDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jing Hua ZhaoMRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Susan R HeckbertCardiovascular Health Research Unit, Department of Epidemiology, Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.
Deborah L JarvisRespiratory Epidemiology and Public Health Group, National Heart and Lung Institute.
Nicole Probst-HenschSwiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland.
Holger SchulzInstitute of Epidemiology I, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
R Graham BarrDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Marjo-Riitta JarvelinDepartment of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College London, London, UK, Institute of Health Sciences, Biocenter Oulu, University of Oulu, Oulu, Finland, Unit of Primary Care, Oulu University Hospital, Oulu, Finland, Department of Children and Young People and Families, National Institute for Health and Welfare, Oulu, Finland.
George T O'ConnorPulmonary Center, Boston University School of Medicine, Boston, MA, USA, The NHLBI's Framingham Heart Study, Framingham, MA, USA.
Mika KähönenDepartment of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Patricia A CassanoDivision of Nutritional Sciences, Cornell University, Ithaca, NY, USA, Department of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, NY, USA.
Pirro G HysiDepartment of Twins Research and Genetic Epidemiology, King's College, London, UK.
Josée DupuisThe NHLBI's Framingham Heart Study, Framingham, MA, USA, Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Caroline HaywardMRC Human Genetics Unit, MRC IGMM.
Bruce M PsatyDepartment of Medicine, Cardiovascular Health Research Unit, Department of Epidemiology, Department of Health Services, University of Washington, Seattle, WA, USA, Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA.
Ian P HallDivision of Respiratory Medicine, University Hospital of Nottingham, Nottingham, UK.
William C ParksDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA and.
Martin D TobinGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK, National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
Stephanie J LondonEpidemiology Branch, National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services, Research Triangle Park, NC, USA.
CHARGE Consortium
SpiroMeta Consortium
Cornell University · USErasmus MC · NLKaiser Permanente Washington Health Research Institute · USMRC Human Genetics UnitNational Institute for Health Research · GBAddenbrooke's Hospital · GBBoston University · USCedars-Sinai Medical Center · USColumbia University · USFaculty of Public Health · GBFinnish Institute for Health and Welfare · FIFramingham Heart Study · USHelmholtz Zentrum München · DEIcelandic Heart Association · ISInstitut des Sciences Cognitives Marc Jeannerod · FRInstitute of Genetics and Cancer · GBKing's College London · GBLaboratory of Molecular Genetics · PLLung Institute · USMRC Epidemiology Unit · GB

Funding

Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
CHARGE Consortium: Omics Discovery for CVD and Aging PhenotypesR01HL105756 · NHLBI · UNIVERSITY OF WASHINGTON · PI Bruce M Psaty, NICHOLAS L SMITH · 2011 to 2026
$9.5M
Genetic Analyses For Epidemiologic Studies Of Respiratory DiseaseZIAES025045 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI LONDON, STEPHANIE · 2009 to 2025
$7.3M
Genetics and Environment in Adult Respiratory, Allergic and Cardiac diseaseZIAES043012 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI LONDON, STEPHANIE · 2009 to 2025
$6.4M
Biotechnology and Biological Sciences Research Council BB/F019394/1Chief Scientist Office CZB/4/505Chief Scientist Office ETM/55Medical Research Council G0902313Medical Research Council G1000861Medical Research Council G1001799Medical Research Council MC_PC_12010Medical Research Council MC_PC_U127561128Medical Research Council MC_UU_12013/4Medical Research Council MR/K026992/1Medical Research Council MR/N01104X/1NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01 HL105756
6 · The paper itself

Abstract

Chronic respiratory disorders are important contributors to the global burden of disease. Genome-wide association studies (GWASs) of lung function measures have identified several trait-associated loci, but explain only a modest portion of the phenotypic variability. We postulated that integrating pathway-based methods with GWASs of pulmonary function and airflow obstruction would identify a broader repertoire of genes and processes influencing these traits. We performed two independent GWASs of lung function and applied gene set enrichment analysis to one of the studies and validated the results using the second GWAS. We identified 131 significantly enriched gene sets associated with lung function and clustered them into larger biological modules involved in diverse processes including development, immunity, cell signaling, proliferation and arachidonic acid. We found that enrichment of gene sets was not driven by GWAS-significant variants or loci, but instead by those with less stringent association P-values. Next, we applied pathway enrichment analysis to a meta-analyzed GWAS of airflow obstruction. We identified several biologic modules that functionally overlapped with those associated with pulmonary function. However, differences were also noted, including enrichment of extracellular matrix (ECM) processes specifically in the airflow obstruction study. Network analysis of the ECM module implicated a candidate gene, matrix metalloproteinase 10 (MMP10), as a putative disease target. We used a knockout mouse model to functionally validate MMP10's role in influencing lung's susceptibility to cigarette smoke-induced emphysema. By integrating pathway analysis with population-based genomics, we unraveled biologic processes underlying pulmonary function traits and identified a candidate gene for obstructive lung disease.

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single NucleotideAirway ObstructionAnimalsCell ProliferationGenomicsHumansImmune SystemLungMaleMetabolic Networks and PathwaysMicePhenotypeSignal TransductionWhite People

Identifiers

PMID26395457
PMCPMC4643644
OpenAlexW2142909984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.